NewKerala.com

2020 Cannabis Industry Year-End Review

PRN

DENVER

Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider and developer of the cannabis industry's first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform), announced the release of its first annual year-end review.

2020 has become synonymous with the unexpected. While the wheels of commerce turned slowly for much of the world, Akerna and the cannabis industry moved forward at full steam, said Jessica Billingsley, chief executive officer, Akerna. This report provides a curated snapshot of the most important trends and events of 2020. With this collection of business trends and intelligence, you will be armed with knowledge that can help you stay informed and make the best decisions for your business in the year to come.­­

Read the Year-End Review

Cannabis Industry Year-End Review Highlights

Cannabis Capital Markets States Legalization Pushes the Crest of the Cannabis Wave Higher, by Codie Sanchez, Entourage Effect Capital
A Growing Industry Matures The Post-Covid Landscape, by Ben Beckham, Director of Sales, Akerna
Cannabis Reform Sweeps 2020 Elections, by the Akerna Government Relations Team
Innovation and Diversification Cannabis Branding, by Nina Simosko, Chief Commercial Officer, Akerna

About Akerna
Akerna (Nasdaq KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. Based in Denver, Colorado, the Company's mission is to create the world's most transparent and accountable supply chain by building a cannabis technology ecosystem connecting data points across the global cannabis supply chain from seed to sale to self. First launched in 2010, Akerna has tracked more than $20 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq.

Disclaimer: This story was supplied by an external content provider; we do not endorse or accept responsibility for its accuracy, completeness, or any outcomes from relying on it. It is for informational purposes only and does not constitute legal, financial, medical, or other professional advice. Laws and regulations vary and may change; readers should verify accuracy and compliance with local requirements and consult a qualified professional for tailored guidance.

Share this article:

You May Like!